CMT(CMT)
CMT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $285M | $303M |
| Low | $285M | $303M |
| High | $285M | $303M |
| EBITDA Avg | $25M | $36M |
| Low | $25M | $36M |
| High | $25M | $36M |
| EBIT Avg | $13M | $24M |
| Low | $13M | $24M |
| High | $13M | $24M |
| Net Income Avg | $9M | $17M |
| Low | $9M | $17M |
| High | $9M | $17M |
| EPS Avg | $1.04 | $2.00 |
| Low | $1.04 | $2.00 |
| High | $1.04 | $2.00 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $63M | $101M | $69M | $74M | $78M | $82M |
| Low | $63M | $101M | $69M | $74M | $78M | $82M |
| High | $63M | $101M | $69M | $74M | $78M | $82M |
| EBITDA Avg | $7M | $8M | $7M | $9M | $9M | $10M |
| Low | $7M | $8M | $7M | $9M | $9M | $10M |
| High | $7M | $8M | $7M | $9M | $9M | $10M |
| EBIT Avg | $4M | $5M | $4M | $6M | $6M | $7M |
| Low | $4M | $5M | $4M | $6M | $6M | $7M |
| High | $4M | $5M | $4M | $6M | $6M | $7M |
| Net Income Avg | $3M | $3M | $3M | $4M | $4M | $5M |
| Low | $3M | $3M | $3M | $4M | $4M | $5M |
| High | $3M | $3M | $3M | $4M | $4M | $5M |
| EPS Avg | $0.36 | $0.41 | $0.37 | $0.53 | $0.53 | $0.57 |
| Low | $0.36 | $0.41 | $0.37 | $0.53 | $0.53 | $0.57 |
| High | $0.36 | $0.41 | $0.37 | $0.53 | $0.53 | $0.57 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |